IQIRVO
NDC 15054-0080, elafibranor, tablet, film coated, from Ipsen Biopharmaceuticals, Inc..
- Product NDC
- 15054-0080
- Status
- Listed
- Labeler
- Ipsen Biopharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218860
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/15054-0080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELAFIBRANOR80 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inducers [MoA]; Peroxisome Proliferator-activated Receptor Agonist [EPC]; Peroxisome Proliferator-activated Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 15054-0080-1 | 15054008001 | 1 BOTTLE in 1 CARTON (15054-0080-1) / 30 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d78aa14f-6ec1-4b1d-a4ae-e48658137a25
Use it
Look up 15054-0080 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/15054-0080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 15054-0080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.